Moderna Makes Twice as Many Antibodies as Pfizer: Study

Aug.31 -- According to a study, Moderna Inc.’s Covid-19 vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE. Jason Gale reports on "Bloomberg Daybreak: Asia."

Comments / 0

Published by

Bloomberg from Video Elephant


More from Bloomberg Videos (VE)

Comments / 0